UK's Royal Society calls for integration of human/animal R&D and policy
This article was originally published in Clinica
The UK's Royal Society is calling on the government to establish a National Institute for Infectious Diseases (NIID) to better co-ordinate both R&D and policy in areas of disease that affect both humans and animals. A joint, integrated approach, would lead to overall improvements in public health and decrease response times against infectious disease incidents, argues the national academy of science.
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.